Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 4

2(33.3%)

Phase 2

2(33.3%)

6Total

N/A(2)

Phase 4(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06173557Completed

Intraoperative Measurement Technique

Role: lead

NCT04862806Not ApplicableUnknown

Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL

Role: collaborator

NCT04934930Phase 2Unknown

Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status

Role: collaborator

NCT02140580Phase 4Unknown

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Role: collaborator

NCT02356237Not ApplicableTerminated

The Effect of Episiotomy on Maternal and Fetal Outcomes (EPITRIAL)

Role: collaborator

NCT02929953Completed

Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients

Role: collaborator

NCT02477631Phase 2Completed

Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients

Role: collaborator

NCT02640144Phase 4Unknown

The Influence of Hyaluronic Acid Injection Following Knee Arthroscopy

Role: lead

NCT02963012Unknown

The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy

Role: collaborator

NCT02117518Unknown

Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients

Role: collaborator

All 10 trials loaded